Marques-Monteiro Miguel, Teixeira Bernardo, Mendes Gonçalo, Rocha Alexandra, Madanelo Mariana, Mesquita Sofia, Vital João, Vinagre Nuno, Magalhães Martinha, Oliveira Beatriz, Carneiro Diogo, Soares José, Cabral João, Teves Frederico, Fraga Avelino
Urology Department, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
World J Urol. 2023 Oct;41(10):2671-2677. doi: 10.1007/s00345-023-04571-0. Epub 2023 Sep 5.
The Hugo™ RAS system is a novel robotic platform with innovative features. However, there are currently no available data on extraperitoneal robot-assisted radical prostatectomy (RARP) performed using this system. The objective of this study is to describe the surgical setup and assess the safety and feasibility of the extraperitoneal approach in robotic radical prostatectomy with the Hugo™ RAS system.
Sixteen consecutive patients diagnosed with localized prostate cancer underwent extraperitoneal RARP ± lymph node dissection at our institution, between March and May 2023. All RARP procedures were performed extraperitoneal with a modular four-arm configuration. The focus was to describe the operative room setup, trocar placement, tilt and docking angles and evaluate the safety and feasibility of this approach with this robotic platform. Secondary outcomes recorded included, total operative time, console time, estimated bleeding, intra- and postoperative complications, and length of stay after surgery. A descriptive analysis was conducted.
We report on the first sixteen cases of extraperitoneal robot-assisted radical prostatectomy performed with the new Hugo™ RAS system. All procedures were completed, without the need for conversion or placement of additional ports. No intraoperative complications or major technical failures that would prevent the completion of surgery were recorded. The median operative time was 211 min (IQR 180-277), and the median console time was 152 min (IQR 119-196). The mean docking time was 4.6 min (IQR 4.1-5.2). The median estimated blood loss and the median time to remove the vesical catheter were 200 mL (IQR 150-400) and 8 days (IQR 7-8), respectively. The median length of stay was 2 days (IQR 2-2). Only one minor complication was registered in the first 30 days.
This study provides evidence of the safety and feasibility of the extraperitoneal approach in RARP with the Hugo™ RAS system. The description of the surgical setup in terms of trocar placement, arm-cart disposition, tilt and docking angles offers valuable information for surgeons interested in adopting this surgical approach with the Hugo™ RAS platform.
Hugo™ RAS系统是一个具有创新特性的新型机器人平台。然而,目前尚无关于使用该系统进行腹膜外机器人辅助根治性前列腺切除术(RARP)的可用数据。本研究的目的是描述手术设置,并评估在使用Hugo™ RAS系统的机器人根治性前列腺切除术中腹膜外入路的安全性和可行性。
2023年3月至5月期间,16例连续诊断为局限性前列腺癌的患者在我院接受了腹膜外RARP±淋巴结清扫术。所有RARP手术均采用模块化四臂配置在腹膜外进行。重点是描述手术室设置、套管针放置、倾斜和对接角度,并评估使用该机器人平台的这种入路的安全性和可行性。记录的次要结果包括总手术时间、控制台时间、估计失血量、术中和术后并发症以及术后住院时间。进行了描述性分析。
我们报告了首例使用新型Hugo™ RAS系统进行的16例腹膜外机器人辅助根治性前列腺切除术。所有手术均顺利完成,无需中转或放置额外的端口。未记录到术中并发症或导致手术无法完成的重大技术故障。中位手术时间为211分钟(四分位间距180 - 277),中位控制台时间为152分钟(四分位间距119 - 196)。平均对接时间为4.6分钟(四分位间距4.1 - 5.2)。中位估计失血量和拔除膀胱导管的中位时间分别为200毫升(四分位间距150 - 400)和8天(四分位间距7 - 8)。中位住院时间为2天(四分位间距2 - 2)。前30天仅记录到1例轻微并发症。
本研究提供了使用Hugo™ RAS系统进行腹膜外入路RARP的安全性和可行性的证据。在套管针放置、臂车配置、倾斜和对接角度方面对手术设置的描述,为有兴趣采用Hugo™ RAS平台这种手术入路的外科医生提供了有价值的信息。